[Federal Register: August 6, 2004 (Volume 69, Number 151)]
[Rules and Regulations]
[Page 47765-47766]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au04-3]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1
[Docket No. 2003D-0545]
Guidance for Industry: Questions and Answers Regarding the
Interim Final Rule on Registration of Food Facilities (Edition 4);
Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of availability of guidance.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a revised guidance entitled ``Questions and Answers
Regarding the Interim Final Rule on Registration of Food Facilities
(Edition 4).'' The guidance responds to various questions raised about
section 305 of the Public Health Security and Bioterrorism Preparedness
and Response Act of 2002 (the Bioterrorism Act) and the agency's
implementing regulation, which require facilities that manufacture/
process, pack, or hold food for consumption in the United States to
register with FDA by December 12, 2003.
DATES: Submit written or electronic comments on the agency guidance at
any time.
ADDRESSES: You may submit comments, identified by Docket No. 2003D-
0545, by any of the following methods:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments.
Agency Web site: http://www.fda.gov/dockets/ecomments.
Follow the instructions for submitting comments on the agency Web site.
E-mail: fdadockets@oc.fda.gov. Include Docket No. 2003D-
0545 in the subject line of your e-mail message.
FAX: 301-827-6870.
Mail/Hand delivery/Courier [For paper, disk, or CD-ROM
submissions]: Division of Dockets Management, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
Instructions: All submissions received must include the agency name
and Docket No. or Regulatory Information Number (RIN) for this
rulemaking. All comments received will be posted without change to
http://www.fda.gov/ohrms/dockets/default/htm, including any personal
information provided. For detailed instructions on submitting comments
and additional information on the rulemaking process, see the
``Comments'' heading of the SUPPLEMENTARY INFORMATION section of this
document.
Docket: For access to the docket to read background documents or
comments received, go to http://www.fda.gov/ohrms/dockets/default/htm
and insert the docket number, found in brackets in the heading of this
document, into the ``Search'' box and follow the prompts and/or go to
the Division of Dockets Management, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Melissa S. Scales, Office of
Regulations and Policy (HFS-24), Center for Food Safety and Applied
Nutrition, Food and Drug Administration, 5100 Paint Branch Pkwy.,
College Park, MD 20740, 301-436-1720.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of October 10, 2003 (68 FR 58894), FDA
issued an interim final rule to implement section 305 of the
Bioterrorism Act. The registration regulation requires facilities that
manufacture/process, pack, or hold food (including animal feed) for
consumption in the United States to register with FDA by December 12,
2003.
On December 4, 2003, FDA issued the first edition of a guidance
entitled ``Questions and Answers Regarding the Interim Final Rule on
Registration of Food Facilities.'' The second edition of this guidance
was issued on January 12, 2004, and the third edition on February 17,
2004. The guidance announced by this document entitled ``Questions and
Answers Regarding the Interim Final Rule on Registration of Food
Facilities (Edition 4)'' is a revision of the February 17, 2004,
guidance and responds to additional questions about the interim final
rule on registration. The guidance is intended to help the industry
better understand and comply with the regulation in 21 CFR part 1,
subpart H.
FDA wishes to highlight one issue clarified in the fourth edition
of the food facility registration guidance, the appropriate designation
of a U.S. agent by a foreign food facility. Since the interim final
rule published, several individuals have notified FDA that, although
listed in a facility's registration as its U.S. agent, the individual
had not agreed to serve as the facility's U.S. agent. Question 14.20 in
the fourth edition clarifies how FDA will handle the registration of a
facility when the agency is notified that the individual listed as the
facility's U.S. agent disagrees with that designation.
FDA is issuing the guidance entitled ``Questions and Answers
Regarding the Interim Final Rule on Registration of Food Facilities
(Edition 4)'' as a level 1 guidance. Consistent with FDA's good
guidance practices (GGPs) regulation Sec. 10.115 (21 CFR 10.115), the
agency will accept comments on this guidance, but it is implementing
the guidance immediately, in accordance with Sec. 10.115(g)(2),
because the agency has determined that prior public participation is
not feasible or appropriate. As noted, the Bioterrorism Act requires
covered facilities to be registered with FDA by December 12, 2003.
Clarifying the provisions of the interim final rule will facilitate
prompt registration by covered facilities and thus, complete
implementation of the interim final rule.
As noted in previous notices announcing the availability of
guidance for food facility registration, FDA continues to respond to
requests for clarification of the registration interim final rule by
providing guidance in a question-and-answer format. The agency is
maintaining all responses to questions concerning food facility
registration in a single document that is periodically updated as the
agency responds to additional questions. The following four indicators
are employed to help users of the guidance identify revisions: (1) The
guidance will be identified as a revision of a previously issued
document, (2) the revision date of the guidance will appear on its
cover, (3) the edition number of the guidance will be included in its
title, and (4) new questions and answers will be identified as such in
the body of the guidance.
II. Comments
Interested persons may, at any time, submit written or electronic
comments
[[Page 47766]]
to the Division of Dockets Management (see ADDRESSES) regarding this
guidance. Submit a single copy of electronic comments or two paper
copies of any mailed comments, except that individuals may submit one
copy. Comments are to be identified with the docket number found in
brackets in the heading of this document. The guidance and received
comments may be seen in the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.
III. Electronic Access
Persons with access to the Internet may obtain the document at
http://www/cfsan.fda.gov/guidance.html.
Dated: August 2, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-18057 Filed 8-4-04; 8:45 am]
BILLING CODE 4160-01-S